- 全部删除
您的购物车当前为空
ELOVL1-IN-1 (1-(2-Fluorophenyl)-N-(1-(2-fluoropyridin-4-YL)-1H-pyrazol-3-YL)cyclopropane-1-carboxamide) 是ELOVL1抑制剂,能够降低超长链脂肪酸的水平,可用于肾上腺脑白质营养不良的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
ELOVL1-IN-1 (1-(2-Fluorophenyl)-N-(1-(2-fluoropyridin-4-YL)-1H-pyrazol-3-YL)cyclopropane-1-carboxamide) 是ELOVL1抑制剂,能够降低超长链脂肪酸的水平,可用于肾上腺脑白质营养不良的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,650 | In stock | |
| 5 mg | ¥ 3,380 | In stock | |
| 10 mg | ¥ 4,830 | In stock | |
| 25 mg | ¥ 7,380 | In stock | |
| 50 mg | ¥ 9,870 | In stock | |
| 100 mg | ¥ 13,300 | In stock | |
| 200 mg | ¥ 17,900 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,530 | In stock |
| 产品描述 | ELOVL1-IN-1 (1-(2-Fluorophenyl)-N-(1-(2-fluoropyridin-4-YL)-1H-pyrazol-3-YL)cyclopropane-1-carboxamide) is an ELOVL1 inhibitor. ELOVL1-IN-1 can reduce the levels of very long chain fatty acids. ELOVL1-IN-1 can be used in the study of adrenoleukodystrophy (ALD). |
| 体外活性 | 给予1 nM-10 μM ELOVL1-IN-1处理48小时,能够降低肾上腺脑白质营养不良(ALD)患者成纤维细胞和健康人成纤维细胞、ALD患者B淋巴细胞以及人类微胶质细胞中的长链脂肪酸(VLCFA)和溶血磷脂酰胆碱(LPC)的水平[1]。 |
| 体内活性 | 口服ELOVL1-IN-1能够显著降低ABCD1基因敲除小鼠(0.5-64 mg/kg;28天)、正常型(WT)大鼠(30-300 mg/kg;7天)和猕猴(30 mg/kg;7天)血液中的长链脂肪酸(VLCFA)水平,具体是C26:0 LPC水平[1]。 |
| 别名 | 1-(2-Fluorophenyl)-N-(1-(2-fluoropyridin-4-YL)-1H-pyrazol-3-YL)cyclopropane-1-carboxamide |
| 分子量 | 340.33 |
| 分子式 | C18H14F2N4O |
| CAS No. | 2227482-41-7 |
| Smiles | Fc1cc(ccn1)-n1ccc(NC(=O)C2(CC2)c2ccccc2F)n1 |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (146.92 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容